1. 2014 “Towards an HIV Cure” symposium Melbourne Cure Research and the Community David Evans, Project Inform

2. What’s been done so far Fred Verdault’s study Gay and bisexual men in the Netherlands Definition of the cure very important: Eliminate future health problems Eliminate risk of reinfection Eliminate risk of transmission Going off of ART less important Study with Nelson Vergel and Michael Arnold Altruism a significant motivator, but… Altruism highest among those seeking a personal benefit from the research

3.  Community Involvement  ACTG  ANRS  MDC Collaboratories

4. Limitations  Populations studied  Survey designs  How much do you have to educate in order to conduct a meaningful survey?

5. Ongoing studies  University of North Carolina study on the ethical dimensions of cure research in Guangzhou and South Africa  ANRS study in France studying psychological and social dimensions of cure research  British study looking at the desirability and willingness to participate in cure research

6. What does a cure even mean?  Mississippi Baby  Canadian Children  Boston Patients  Visconti Cohort

7. What does a cure even mean?  How will trials be designed?  What will be the goals of cure research and how will that mesh with the desires of PLWHIV?  What will we call it? Will or should we even use the “C ” word?

8. Equity in cure research  Will it only be for those who start treatment extremely early or those with cancer?  If we do pediatric research how will we work out the ethics in low income countries?  What should we do about interventions that are likely to be very costly and untransferable to low income countries?

9. Barriers to participation  Time and timing  No benefit over standard ART  Biological samples  Stigma  Treatment Interruptions/Time off therapy  Time intensity  Risks

10. What are inducements to participation?  Altruism  Hope for more information about one’s own health (e.g. return of research results)  Hope for benefit  Financial  Treatment Interruption  Reduced infectiousness/vulnerability